Encouraging Early Outcomes of Treatment With Arsenic Trioxide Combined With Chemotherapy for Alveolar Rhabdomyosarcoma in Children: 4 Case Reports

Encouraging Early Outcomes of Treatment With Arsenic Trioxide Combined With Chemotherapy for Alveolar Rhabdomyosarcoma in Children: 4 Case Reports

BackgroundAlveolar rhabdomyosarcoma (ARMS) is a subtype of rhabdomyosarcoma characterized by its aggressive behavior and poor prognosis, highlighting the need for novel treatment options. Arsenic trioxide (ATO) has been shown to specifically inhibit tumor growth and the metastasis of ARMS in vitro b...

Full description

Bibliographic Details
Main Authors: Xiaomin Peng, Xilin Xiong, Yang Li, Chuchu Feng, Hongyan Liu, Pingping Wu, Chunmou Li, Wenjun Weng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
alveolar rhabdomyosarcoma
arsenic trioxide
chemotherapy
children
ATO
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.751623/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.751623/full

Similar Items